ORBITS

Live / Applied — Suspended — suspension check completed, case still suspended (as of 02 Jan 2026)

What this means for you

Not registered yet, but its 14 Dec 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97716665
Mark type
Stylized text
Filed
14 Dec 2022
Attorney of record
Clifford D. Hyra

Goods and services

  • Class 009 — Scientific and electric apparatus: Downloadable Software as a Medical Device (SaMD) for use in studying and analyzing cancer models and for use as medical image processors; Downloadable medical software for use in drug screening, drug discovery, image processing, image analysis and image storage and for use in studying and analyzing cancer models; Downloadable medical imaging software for recording, monitoring, studying and analyzing cancer models; Downloadable medical and scientific analysis software for use in drug screening, drug discovery, image processing, image analysis and image storage and for use in studying and analyzing cancer models; Downloadable software for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Downloadable cloud computing software for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Downloadable computer software platforms for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Downloadable software for analyzing microscopic images; Downloadable cloud computing software for analyzing microscopic images; Downloadable computer software platforms for analysing microscopic images; All the aforesaid in particular in the field of cancer research, cancer screening, cancer treatment and cancer diagnosis
  • Class 042 — Scientific and technological services: Providing online, non-downloadable software for use as a medical device for image processing and for studying and analyzing cancer models; Platform as a Service (PAAS) featuring computer software platforms for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Cloud computing featuring software for use in medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Providing temporary use of on-line non-downloadable cloud computing software for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Providing on-line non-downloadable software for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Software as a service (SAAS) services featuring software for medical imaging, image analysis, image storage and image transfer; Software as a service (SAAS) services featuring software for drug screening, testing of pharmaceuticals and drug development; Platform as a Service (PAAS) featuring computer software platforms for analyzing microscopic images; Cloud computing featuring software for use in analysing microscopic images; Providing temporary use of on-line on-downloadable cloud computing software for analysing microscopic images; Providing on-line non-downloadable software for analyzing microscopic images; Software as a service (SAAS) services featuring software for analyzing microscopic images; medical research laboratory services; Medical and scientific research in the field of medical imaging, image analysis, drug screening, testing of pharmaceuticals and drug development; Drug screening for scientific research purposes; Testing of pharmaceuticals; Drug discovery services; Pharmaceutical drug development services; Medical and scientific research, namely, conducting clinical trials for others; All the aforesaid also using artificial intelligence; All the aforesaid in particular in the field of cancer research, cancer screening, cancer treatment and cancer diagnosis

Owner

Prosecution history

  • 02 Jan 2026 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
  • 01 Jul 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
  • 02 Jan 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
  • 02 Feb 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
  • 02 Feb 2024 — LETTER OF SUSPENSION E-MAILED
  • 02 Feb 2024 — SUSPENSION LETTER WRITTEN
  • 16 Jan 2024 — EXAMINER'S AMENDMENT ENTERED
  • 16 Jan 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 16 Jan 2024 — EXAMINERS AMENDMENT E-MAILED
  • 16 Jan 2024 — EXAMINERS AMENDMENT -WRITTEN
  • 11 Dec 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 11 Dec 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 11 Dec 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 21 Sept 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 21 Sept 2023 — NON-FINAL ACTION E-MAILED

View this trademark record on Marksy